https://www.onclive.com/view/dr-mehmi-on-the-rationale-for-investigating-fianlimab-cemiplimab-in-advanced-melanoma
0
0
9/12/23 at 2:50pm
Organization
OncLive
39 words
0
Comments
Inderjit Mehmi, MD, medical oncologist, discusses the rationale for investigating the combination of fianlimab and cemiplimab in patients who have advanced melanoma with poor-risk features
You are the first to view
Create an account
or login to join the discussion